The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High dose interleukin-2 and response in 944 patients with metastatic renal cell cancer (RCC): Data from the PROCLAIM registry.
 
Tanya B. Dorff
Honoraria - Astellas Pharma; Dendreon; Exelixis; Pfizer; Prometheus
Consulting or Advisory Role - Bayer; Dendreon; Eisai; EMD Serono
Speakers' Bureau - Astellas Pharma; Dendreon; Exelixis; Pfizer; Prometheus
Research Funding - Bristol-Myers Squibb
 
Michael K.K. Wong
No Relationships to Disclose
 
Joseph Clark
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Argos Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche (I)
 
Gregory A. Daniels
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Prometheus (Inst); Viralytics (Inst)
 
Brendan D. Curti
Honoraria - Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Agonox; Prometheus
 
Michael Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Genentech/Roche; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Lexicon; Novartis; Taiho Pharmaceutical
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Merck (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Howard Kaufman
Employment - Compass Therapeutics
Leadership - Compass Therapeutics
Honoraria - Amgen; Celldex; Compass Therapeutics; EMD Serono; Merck; Prometheus; Turnstone Bio
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celldex; Compass Therapeutics; Merck; Merck Serono; Prometheus; Turnstone Bio
Speakers' Bureau - Merck
Research Funding - Amgen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - EMD Serono; Turnstone Bio
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Peter Zang
No Relationships to Disclose
 
Nancy C. Gregory
Employment - Prometheus
 
Lisa Maria Eifler
Employment - Prometheus
 
Stephen Thomas
Employment - Prometheus
 
Marci White
Employment - Prometheus
 
Jatinder Singh
No Relationships to Disclose
 
Janice P. Dutcher
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Medarex; Eisai; Merck; Nektar; Prometheus; TRACON Pharma
Speakers' Bureau - Exelixis; Prometheus
Travel, Accommodations, Expenses - Exelixis; Prometheus